Sandeep Batra, M.D.
Riley Hospital Pediatric Hematology/Oncology Department
11700 N. Meridian St., Ste. C240
Carmel
317-688-4673
Riley at IU Health North
Special Expertise Leukemia & Lymphoma, Solid Tumors, Brain Tumors
James M. Croop, M.D.
Riley Hospital–Pediatric Hematology/Oncology
705 Riley Hospital Dr.
317-944-2143
Riley
Special Expertise solid tumors, clinical trials
Robert J. Fallon, M.D.
Riley Hospital–Pediatric Hematology/Oncology
705 Riley Hospital Dr.
317-944-2143
Riley
Special Expertise lymphoma, Hodgkin’s lymphoma, stem-cell transplant
Jessica F. Goodman, M.D.
Peyton Manning Children’s Hospital Center for Cancer & Blood Diseases
2001 W. 86th St.
317-338-4673
Peyton Manning
Special Expertise pediatric cancers, brain tumors
PAUL R. HAUT, M.D.
Riley Hematology & Oncology
705 Riley Hospital Dr., Ste. 4340
317-944-2143
Riley
IU Health North
Special Expertise Stem Cell Transplant, Bone Marrow Transplant, Leukemia
KENNETH H. LAZARUS, M.D.
Riley Hospital Pediatric Hematology/Oncology Department
11700 N. Meridian St., Ste. C240
Carmel
317-688-4673
Riley at IU Health North
Special Expertise Immune Deficiency, Leukemia & Lymphoma
Kamnesh R. Pradhan, M.D.
Riley Hospital–Pediatric Hematology/Oncology
705 Riley Hospital Dr.
317-944-2143
Riley
Special Expertise neuro-oncology, brain tumors
Bassem I. Razzouk, M.D.
Peyton Manning Children’s Hospital Center for Cancer & Blood Diseases
2001 W. 86th St.
317-338-4673
Peyton Manning
Special Expertise leukemia, clinical trials, lymphoma, Langerhans Cell Histiocytosis (LCH)
JAMIE L. RENBARGER, M.D.
Riley Hospital Pediatric Hematology-Oncology
705 Riley Hospital Dr., Ste. 4340
317-944-2143
Riley
Special Expertise Bone Marrow & Stem Cell Transplant
Amy D. Shapiro, M.D.
Indiana Hemophilia & Thrombosis Center
8402 Harcourt Rd., Ste. 500
317-871-0000
Peyton Manning
Special Expertise hemophilia, bleeding/coagulation disorders, pediatric hematology
Terry A. Vik, M.D.
Riley Hospital–Pediatric Hematology/Oncology
705 Riley Hospital Dr.
317-944-2143
Riley
Special Expertise neuroblastoma, cancer survivors–late effects of therapy, leukemia, drug development
